Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma

Detalles Bibliográficos
Autores principales: Liang, Zhiyu, Li, Ping, Kang, Liqing, Zhou, Lili, Xu, Yang, Ye, Shiguang, Du, Juan, Li, Bing, Wang, Yiwen, Yu, Lei, Qian, Wenbin, Liang, Aibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753190/
https://www.ncbi.nlm.nih.gov/pubmed/34758063
http://dx.doi.org/10.1182/bloodadvances.2021005814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753190/
https://www.ncbi.nlm.nih.gov/pubmed/34758063
http://dx.doi.org/10.1182/bloodadvances.2021005814

Ejemplares similares